Sep 13, 2022 / 06:55PM GMT
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity Analyst
Good afternoon, and thank you for joining us for the second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong. I'm medical device analyst here at Morgan Stanley. It's my pleasure to have Embecta new spin-out first conference with us, invite the CEO, Dev Kurdikar; CFO, Jake Elguicze. Thank you both very much for being here.
Devdatt Kurdikar - Embecta Corp. - President, CEO & Director
Thank you, Cecilia, for having us, and thank you for those in the room that are here to listen to our story. And just sort of before we get started, you recognize that we might be making forward-looking statements and obviously risks and uncertainties associated with that. And in our filings and the SEC website, including our latest 10-Q, always refer to that if you have any questions. But with that, ready to jump in. Jake and I are here and wanting to answer your questions, Cecilia.
Cecilia E. Furlong - Morgan Stanley, Research Division - Equity Analyst
Embecta Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers